Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novocure Ltd Ord Sh
(NQ:
NVCR
)
17.90
-1.01 (-5.34%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novocure Ltd Ord Sh
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
June 06, 2023
From
Novocure
Via
Business Wire
Novocure Pledges $3 Million to Conquer Cancer®, the ASCO Foundation, to Support Cancer Research and Education
June 01, 2023
From
Novocure
Via
Business Wire
3 No-Brainer Stocks to Buy for Under $100 Right Now
May 27, 2023
These stocks might not remain under $100 for too much longer.
Via
The Motley Fool
NovoCure's Return On Capital Employed Overview
May 18, 2023
Via
Benzinga
4 Analysts Have This to Say About NovoCure
May 16, 2023
Via
Benzinga
Should You Buy Novocure Stock Right Now?
May 05, 2023
Most Wall Street analysts think this stock will skyrocket. They could be right.
Via
The Motley Fool
NovoCure (NVCR) Q1 2023 Earnings Call Transcript
May 04, 2023
NVCR earnings call for the period ending March 31, 2023.
Via
The Motley Fool
Novocure Stock Dips As Q1 Earnings Miss Estimates, Higher Costs Hurt Bottom Line
May 04, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023
May 16, 2023
Via
Benzinga
NovoCure: Q1 Earnings Insights
May 04, 2023
Via
Benzinga
Novocure Reports First Quarter 2023 Financial Results
May 04, 2023
From
Novocure
Via
Business Wire
The 3 Most Promising Healthcare Tech Stocks for April 2023
April 26, 2023
The best healthcare tech stocks provide investors with impressive upside potential, while promising to improve the healthcare sector.
Via
InvestorPlace
What 4 Analyst Ratings Have To Say About NovoCure
March 17, 2023
Via
Benzinga
2 Best Defensive Stocks to Buy in March
March 08, 2023
These two defensive stocks should shine in the event of a marketwide correction.
Via
The Motley Fool
NovoCure Earnings Perspective: Return On Capital Employed
February 27, 2023
Via
Benzinga
Why NovoCure Stock Is Falling Today
February 23, 2023
Investors were looking for a stronger Q4 from the cancer company.
Via
The Motley Fool
Novocure Announces Presentation of Results of the LUNAR Phase 3 Clinical Trial in Non-Small Cell Lung Cancer at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
April 26, 2023
From
Novocure
Via
Business Wire
Novocure Announces 27 Presentations, Including Real-World Evidence and Preclinical Research, at American Association for Cancer Research (AACR) Annual Meeting 2023
April 14, 2023
From
Novocure
Via
Business Wire
Novocure to Report First Quarter 2023 Financial Results
April 03, 2023
From
Novocure
Via
Business Wire
NovoCure (NVCR) Q4 2022 Earnings Call Transcript
February 23, 2023
NVCR earnings call for the period ending December 31, 2022.
Via
The Motley Fool
Why Novocure Stock Was so Healthy Today
February 15, 2023
There was good news from the laboratory on Hump Day.
Via
The Motley Fool
Kristin Stafford Joins Novocure Board of Directors
March 29, 2023
From
Novocure
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
March 17, 2023
Via
Benzinga
Novocure Announces 5th Annual AACR-Novocure Grants for Tumor Treating Fields Research Program
March 16, 2023
From
Novocure
Via
Business Wire
2 Stocks That Could Rebound and Rise 30% or More in 2023
March 10, 2023
They're down, but they aren't yet out.
Via
The Motley Fool
Novocure Announces Reimbursement of Optune® for the Treatment of Newly Diagnosed Glioblastoma in France
March 01, 2023
From
Novocure
Via
Business Wire
Novocure Announces Last Patient Enrolled in Pivotal METIS Study of Tumor Treating Fields in Brain Metastases from Non-Small Cell Lung Cancer
March 01, 2023
From
Novocure
Via
Business Wire
Novocure Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update
February 23, 2023
From
Novocure
Via
Business Wire
Allyson J. Ocean, M.D., Joins Novocure Board of Directors
February 23, 2023
From
Novocure
Via
Business Wire
Earnings Scheduled For February 23, 2023
February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.